Impact of variation in acute virulence of BVDV1 strains on design of better vaccine efficacy challenge models

Vaccine

Volumn 25, Issue 47, 2007, Pages 8058-8066

  Ridpath, Julia F ^a   Neill, John D ^a   Peterhans, Ernst ^b  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Acute challenge model; Bovine viral diarrhea virus; Vaccine efficacy

Indexed keywords

VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BOVINE DIARRHEA VIRUS; CONTROLLED STUDY; DRUG EFFICACY; INFECTION; INOCULATION; NONHUMAN; PRIORITY JOURNAL; VIRUS STRAIN; VIRUS VIRULENCE;

ACUTE DISEASE; ANIMALS; BODY TEMPERATURE; CATTLE; CELL LINE; DIARRHEA VIRUS 1, BOVINE VIRAL; LYMPHOCYTE COUNT; MODELS, IMMUNOLOGICAL; PESTIVIRUS INFECTIONS; PLATELET COUNT; VIRAL VACCINES; VIRULENCE; VIRUS REPLICATION;

EID: 35548934212     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.09.014     Document Type: Article

References (56)

1. Moerman A., Straver P.J., de Jong M.C., Quak J., Baanvinger T., and van Oirschot J.T. Clinical consequences of a bovine virus diarrhoea virus infection in a dairy herd: a longitudinal study. Vet Q 16 2 (1994) 115-119
2. Evermann J.F., and Barrington G.M. Clinical features. In: Goyal S.M., and Ridpath J.F. (Eds). Bovine viral diarrhea virus: diagnosis, management and control (2005), Blackwell Publishing, Ames, IA 105-120
3. Bolin S.R. Bovine viral diarrhea viruses in mixed infections. In: Brogden K.M., and Guthmiller J.M. (Eds). Polymicrobial diseases (2002), ASM Press, Washington, DC 33-50
4. Ridpath J.F., Bolin S.R., and Dubovi E.J. Segregation of bovine viral diarrhea virus into genotypes. Virology 205 1 (1994) 66-74
5. Pellerin C., van den Hurk J., Lecomte J., and Tussen P. Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities. Virology 203 2 (1994) 260-268
6. Cortese V.S., West K.H., Hassard L.E., Carman S., and Ellis J.A. Clinical and immunologic responses of vaccinated and unvaccinated calves to infection with a virulent type-II isolate of bovine viral diarrhea virus. J Am Vet Med Assoc 213 9 (1998) 1312-1319
7. Ellis J., West K., Cortese V., Konoby C., and Weigel D. Effect of maternal antibodies on induction and persistence of vaccine-induced immune responses against bovine viral diarrhea virus type II in young calves. J Am Vet Med Assoc 219 3 (2001) 351-356
8. Fulton R.W., Step D.L., Ridpath J.F., Saliki J.T., Confer A.W., Johnson B.J., et al. Response of calves persistently infected with noncytopathic bovine viral diarrhea virus (BVDV) subtype 1b after vaccination with heterologous BVDV strains in modified live virus vaccines and mannheimia haemolytica bacterin-toxoid. Vaccine 21 21-22 (2003) 2980-2985
9. Fulton R.W., Ridpath J.F., Confer A.W., Saliki J.T., Burge L.J., and Payton M.E. Bovine viral diarrhoea virus antigenic diversity: impact on disease and vaccination programmes. Biologicals 31 2 (2003) 89-95
10. Makoschey B., Janssen M.G., Vrijenhoek M.P., Korsten J.H., and Marel P. An inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine affords clinical protection against BVDV type 2. Vaccine 19 23/24 (2001) 3261-3268
11. Hamers C., Couvreur B., Dehan P., Letellier C., Fischer L., Brun A.J., et al. Assessment of the clinical and virological protection provided by a commercial inactivated bovine viral diarrhoea virus genotype 1 vaccine against a BVDV genotype 2 challenge. Vet Rec 153 8 (2003) 236-240
12. Vilcek S., Paton D.J., Durkovic B., Strojny L., Ibata G., Moussa A., et al. Bovine viral diarrhoea virus genotype 1 can be separated into at least eleven genetic groups. Arch Virol 146 1 (2001) 99-115
13. Flores E.F., Ridpath J.F., Weiblen R., Vogel F.S., and Gil L.H. Phylogenetic analysis of Brazilian bovine viral diarrhea virus type 2 (BVDV-2) isolates: evidence for a subgenotype within BVDV-2. Virus Res 87 1 (2002) 51-60
14. Fulton R.W., Saliki J.T., Confer A.W., Burge L.J., d'Offay J.M., Helman R.G., et al. Bovine viral diarrhea virus cytopathic and noncytopathic biotypes and type 1 and 2 genotypes in diagnostic laboratory accessions: clinical and necropsy samples from cattle. J Vet Diagn Invest 12 1 (2000) 33-38
15. Fulton R.W., Ridpath J.F., Saliki J.T., Briggs R.E., Confer A.W., Burge L.J., et al. Bovine viral diarrhea virus (BVDV) 1b: predominant BVDV subtype in calves with respiratory disease. Can J Vet Res 66 3 (2002) 181-190
16. Fulton R.W., Ridpath J.F., Ore S., Confer A.W., Saliki J.T., Burge L.J., et al. Bovine viral diarrhoea virus (BVDV) subgenotypes in diagnostic laboratory accessions: distribution of BVDV1a, 1b, and 2a subgenotypes. Vet Microbiol 111 1-2 (2005) 35-40
17. Fulton R.W., Hessman B., Johnson B.J., Ridpath J.F., Saliki J.T., Burge L.J., et al. Evaluation of diagnostic tests used for detection of bovine viral diarrhea virus and prevalence of subtypes 1a, 1b, and 2a in persistently infected cattle entering a feedlot. J Am Vet Med Assoc 228 4 (2006) 578-584
18. Evermann J.F., and Ridpath J.F. Clinical and epidemiologic observations of bovine viral diarrhea virus in the northwestern United States. Vet Microbiol 89 2-3 (2002) 129-139
19. Ridpath J.F., and Bolin S.R. Differentiation of types 1a, 1b and 2 bovine viral diarrhoea virus (BVDV) by PCR. Mol Cell Probes 12 2 (1998) 101-106
20. Bolin S.R., and Ridpath J.F. Prevalence of bovine viral diarrhea virus genotypes and antibody against those viral genotypes in fetal bovine serum. J Vet Diagn Invest 10 2 (1998) 135-139
21. Liebler-Tenorio E.M., Ridpath J.E., and Neill J.D. Distribution of viral antigen and development of lesions after experimental infection with highly virulent bovine viral diarrhea virus type 2 in calves. Am J Vet Res 63 11 (2002) 1575-1584
22. Liebler-Tenorio E.M., Ridpath J.F., and Neill J.D. Lesions and tissue distribution of viral antigen in severe acute versus subclinical acute infection with BVDV2. Biologicals 31 2 (2003) 119-122
23. Liebler-Tenorio E.M., Ridpath J.F., and Neill J.D. Distribution of viral antigen and development of lesions after experimental infection of calves with a BVDV 2 strain of low virulence. J Vet Diagn Invest 15 3 (2003) 221-232
24. Carman S., van Dreumel T., Ridpath J., Hazlett M., Alves D., Dubovi E., et al. Severe acute bovine viral diarrhea in Ontario, 1993-1995. J Vet Diagn Invest 10 1 (1998) 27-35
25. Ridpath J.F., Neill J.D., Frey M., and Landgraf J.G. Phylogenetic, antigenic and clinical characterization of type 2 BVDV from North America. Vet Microbiol 77 1-2 (2000) 145-155
26. Odeon A.C., Kelling C.L., Marshall D.J., Estela E.S., Dubovi E.J., and Donis R.O. Experimental infection of calves with bovine viral diarrhea virus genotype II (NY-93). J Vet Diagn Invest 11 3 (1999) 221-228
27. Kelling C.L., Steffen D.J., Topliff C.L., Eskridge K.M., Donis R.O., and Higuchi D.S. Comparative virulence of isolates of bovine viral diarrhea virus type II in experimentally inoculated six- to nine-month-old calves. Am J Vet Res 63 10 (2002) 1379-1384
28. Corapi W.V., French T.W., and Dubovi E.J. Severe thrombocytopenia in young calves experimentally infected with noncytopathic bovine viral diarrhea virus. J Virol 63 9 (1989) 3934-3943
29. Corapi W.V., Elliott R.D., French T.W., Arthur D.G., Bezek D.M., and Dubovi E.J. Thrombocytopenia and hemorrhages in veal calves infected with bovine viral diarrhea virus. J Am Vet Med Assoc 196 4 (1990) 590-596
30. Bolin S.R., and Ridpath J.F. Differences in virulence between two noncytopathic bovine viral diarrhea viruses in calves. Am J Vet Res 53 11 (1992) 2157-2163
31. Fairbanks K., Schnackel J., and Chase C.C. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge. Vet Ther 4 1 (2003) 24-34
32. Clifford JR. In: Services/APHIS/USDA V, editor. Department of veterinary services memorandum no. 800.97 standard reference preparations, test reagents, and seed cultures for laboratory test reagents; 2006.
33. Castrucci G., Frigeri F., Ferrari M., and Traldi V. The vaccination and challenge with bovine viral diarrhea virus (BVDV) of calves previously infected with a non-cytopathic BVDV. Comp Immunol Microbiol Infect Dis 14 1 (1991) 31-38
34. Title 9 Code of Federal Regulations (9CFR) Title 9 Code of Federal Regulations (9CFR) killed BVD vaccine. In: Biologics/APHIS/USDA CfV, editor; 1974 [ammended 1991].
35. Title 9 Code of Federal Regulations (9CFR) Title 9 Code of Federal Regulations (9CFR) Modified live BVD vaccine. In: Biologics/APHIS/USDA CfV, editor; 1990.
36. CVB Notice 02CVB Notice 02-1919 Vaccine Claims for Protection of the Fetus against BVDV. In: Biologics/APHIS/USDA CfV, editor; 2002.
37. Lee K.M., and Gillespie J.H. Propagation of virus diarrhea virus of cattle in tissue culture. Am J Vet Res 18 (1957) 952-953
38. Gillespie J., Baker J., and McEntee K. A cytopathogenic strains of virus diarrhea virus. Cornell Veterinarian 50 (1960) 73-79
39. Ridpath J.F., Neill J.D., Vilcek S., Dubovi E.J., and Carman S. Multiple outbreaks of severe acute BVDV in North America occurring between 1993 and 1995 linked to the same BVDV2 strain. Vet Microbiol 114 3-4 (2006) 196-204
40. Ridpath J.F., Hietala S.K., Sorden S., and Neill J.D. Evaluation of the reverse transcription-polymerase chain reaction/probe test of serum samples and immunohistochemistry of skin sections for detection of acute bovine viral diarrhea infections. J Vet Diagn Invest 14 4 (2002) 303-307
41. Stoffregen B., Bolin S.R., Ridpath J.F., and Pohlenz J. Morphologic lesions in type 2 BVDV infections experimentally induced by strain BVDV2-1373 recovered from a field case. Vet Microbiol 77 1-2 (2000) 157-162
42. Bolin S.R., and Ridpath J.F. Range of viral neutralizing activity and molecular specificity of antibodies induced in cattle by inactivated bovine viral diarrhea virus vaccines. Am J Vet Res 51 5 (1990) 703-707
43. Dunnett C. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50 (1955) 1096-1121
44. Snedecor W.G., and Cochran G.W. Least significant difference (LSD) method. In: Snedecor W., and Cochran G. (Eds). Statistical methods. 6th ed. (1967), Blackwell Pub Professional, Ames, IA 271-275
45. Ridpath J.F. Practical significance of heterogeneity among BVDV strains: impact of biotype and genotype on U.S. control programs. Prev Vet Med 72 1-2 (2005) 17-30 [discussion 215-9]
46. Baker J., York C., Gillepsie J., and Mitchell G. Virus diarrhea in cattle. Am J Vet Res 15 (1954) 525-531
47. Walz P.H., Bell T.G., Steficek B.A., Kaiser L., Maes R.K., and Baker J.C. Experimental model of type II bovine viral diarrhea virus-induced thrombocytopenia in neonatal calves. J Vet Diagn Invest 11 6 (1999) 505-514
48. Walz P.H., Steficek B.A., Baker J.C., Kaiser L., and Bell T.G. Effect of experimentally induced type II bovine viral diarrhea virus infection on platelet function in calves. Am J Vet Res 60 11 (1999) 1396-1401
49. Walz P.H., Bell T.G., Grooms D.L., Kaiser L., Maes R.K., and Baker J.C. Platelet aggregation responses and virus isolation from platelets in calves experimentally infected with type I or type II bovine viral diarrhea virus. Can J Vet Res 65 4 (2001) 241-247
50. Hamers C., Couvreur B., Dehan P., Letellier C., Lewalle P., Pastoret P.P., et al. Differences in experimental virulence of bovine viral diarrhoea viral strains isolated from haemorrhagic syndromes. Vet J 160 3 (2000) 250-258
51. Bezek D.M., Grohn Y.T., and Dubovi E.J. Effect of acute infection with noncytopathic or cytopathic bovine viral diarrhea virus isolates on bovine platelets. Am J Vet Res 55 8 (1994) 1115-1119
52. Walz P.H., Bell T.G., Wells J.L., Grooms D.L., Kaiser L., Maes R.K., et al. Relationship between degree of viremia and disease manifestation in calves with experimentally induced bovine viral diarrhea virus infection. Am J Vet Res 62 7 (2001) 1095-1103
53. Liebler-Tenorio E.M., Greiser-Wilke I., and Pohlenz J.F. Organ and tissue distribution of the antigen of the cytopathogenic bovine virus diarrhea virus in the early and advanced phase of experimental mucosal disease. Arch Virol 142 8 (1997) 1613-1634
54. Liebler-Tenorio E.M., and Pohlenz J.F. Experimental mucosal disease of cattle: changes in cell proliferation in lymphoid tissues and intestinal epithelium. J Comp Pathol 117 4 (1997) 339-350
55. Frink S., Grummer B., Pohlenz J.F., and Liebler-Tenorio E.M. Changes in distribution and numbers of CD4+ and CD8+ T-lymphocytes in lymphoid tissues and intestinal mucosa in the early phase of experimentally induced early onset mucosal disease in cattle. J Vet Med B Infect Dis Vet Public Health 49 10 (2002) 476-483
56. Polak M.P., and Zmudzinski J.F. Experimental inoculation of calves with laboratory strains of bovine viral diarrhea virus. Comp Immunol Microbiol Infect Dis 23 3 (2000) 141-151